376 related articles for article (PubMed ID: 24051136)
1. Selective potentiation of (α4)3(β2)2 nicotinic acetylcholine receptors augments amplitudes of prefrontal acetylcholine- and nicotine-evoked glutamatergic transients in rats.
Grupe M; Paolone G; Jensen AA; Sandager-Nielsen K; Sarter M; Grunnet M
Biochem Pharmacol; 2013 Nov; 86(10):1487-96. PubMed ID: 24051136
[TBL] [Abstract][Full Text] [Related]
2. Unravelling the mechanism of action of NS9283, a positive allosteric modulator of (α4)3(β2)2 nicotinic ACh receptors.
Grupe M; Jensen AA; Ahring PK; Christensen JK; Grunnet M
Br J Pharmacol; 2013 Apr; 168(8):2000-10. PubMed ID: 23278456
[TBL] [Abstract][Full Text] [Related]
3. Prefrontal beta2 subunit-containing and alpha7 nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signaling.
Parikh V; Ji J; Decker MW; Sarter M
J Neurosci; 2010 Mar; 30(9):3518-30. PubMed ID: 20203212
[TBL] [Abstract][Full Text] [Related]
4. Glutamatergic contributions to nicotinic acetylcholine receptor agonist-evoked cholinergic transients in the prefrontal cortex.
Parikh V; Man K; Decker MW; Sarter M
J Neurosci; 2008 Apr; 28(14):3769-80. PubMed ID: 18385335
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional studies of the modulator NS9283 reveal agonist-like mechanism of action at α4β2 nicotinic acetylcholine receptors.
Olsen JA; Ahring PK; Kastrup JS; Gajhede M; Balle T
J Biol Chem; 2014 Sep; 289(36):24911-21. PubMed ID: 24982426
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of nicotine taking and seeking in rats by the stoichiometry-selective alpha4beta2 nicotinic acetylcholine receptor positive allosteric modulator NS9283.
Maurer JJ; Sandager-Nielsen K; Schmidt HD
Psychopharmacology (Berl); 2017 Feb; 234(3):475-484. PubMed ID: 27844094
[TBL] [Abstract][Full Text] [Related]
7. Two distinct allosteric binding sites at α4β2 nicotinic acetylcholine receptors revealed by NS206 and NS9283 give unique insights to binding activity-associated linkage at Cys-loop receptors.
Olsen JA; Kastrup JS; Peters D; Gajhede M; Balle T; Ahring PK
J Biol Chem; 2013 Dec; 288(50):35997-6006. PubMed ID: 24169695
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of cognitive function by NS9283, a stoichiometry-dependent positive allosteric modulator of α2- and α4-containing nicotinic acetylcholine receptors.
Timmermann DB; Sandager-Nielsen K; Dyhring T; Smith M; Jacobsen AM; Nielsen EØ; Grunnet M; Christensen JK; Peters D; Kohlhaas K; Olsen GM; Ahring PK
Br J Pharmacol; 2012 Sep; 167(1):164-82. PubMed ID: 22506660
[TBL] [Abstract][Full Text] [Related]
9. Discriminative-stimulus effects of NS9283, a nicotinic α4β2* positive allosteric modulator, in nicotine-discriminating rats.
Mohler EG; Franklin SR; Rueter LE
Psychopharmacology (Berl); 2014 Jan; 231(1):67-74. PubMed ID: 23925734
[TBL] [Abstract][Full Text] [Related]
10. Unraveling amino acid residues critical for allosteric potentiation of (α4)3(β2)2-type nicotinic acetylcholine receptor responses.
Wang ZJ; Deba F; Mohamed TS; Chiara DC; Ramos K; Hamouda AK
J Biol Chem; 2017 Jun; 292(24):9988-10001. PubMed ID: 28446611
[TBL] [Abstract][Full Text] [Related]
11. Positive allosteric modulation of α4β2 nAChR agonist induced behaviour.
Rode F; Munro G; Holst D; Nielsen EØ; Troelsen KB; Timmermann DB; Rønn LC; Grunnet M
Brain Res; 2012 Jun; 1458():67-75. PubMed ID: 22552114
[TBL] [Abstract][Full Text] [Related]
12. An Accessory Agonist Binding Site Promotes Activation of α4β2* Nicotinic Acetylcholine Receptors.
Wang J; Kuryatov A; Sriram A; Jin Z; Kamenecka TM; Kenny PJ; Lindstrom J
J Biol Chem; 2015 May; 290(22):13907-18. PubMed ID: 25869137
[TBL] [Abstract][Full Text] [Related]
13. Selective Potentiation of the (α4)
Appiani R; Viscarra F; Biggin PC; Bermudez I; Giraudo A; Pallavicini M; Bolchi C
ACS Chem Neurosci; 2024 Apr; 15(7):1501-1514. PubMed ID: 38511291
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of attentional performance by selective stimulation of alpha4beta2(*) nAChRs: underlying cholinergic mechanisms.
Howe WM; Ji J; Parikh V; Williams S; Mocaër E; Trocmé-Thibierge C; Sarter M
Neuropsychopharmacology; 2010 May; 35(6):1391-401. PubMed ID: 20147893
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of a neuronal nicotinic receptor via pseudo-agonist site.
Mazzaferro S; Bermudez I; Sine SM
Cell Mol Life Sci; 2019 Mar; 76(6):1151-1167. PubMed ID: 30600358
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of (α4)2(β2)3, but not (α4)3(β2)2, nicotinic acetylcholine receptors reduces nicotine self-administration and withdrawal symptoms.
Hamouda AK; Bautista MR; Akinola LS; Alkhlaif Y; Jackson A; Carper M; Toma WB; Garai S; Chen YC; Thakur GA; Fowler CD; Damaj MI
Neuropharmacology; 2021 Jun; 190():108568. PubMed ID: 33878302
[TBL] [Abstract][Full Text] [Related]
17. Neuropharmacological modulation of the P3-like event-related potential in a rat two-tone auditory discrimination task with modafinil and NS9283, a positive allosteric modulator of α4β2 nAChRs.
Grupe M; Grunnet M; Laursen B; Bastlund JF
Neuropharmacology; 2014 Apr; 79():444-55. PubMed ID: 24361451
[TBL] [Abstract][Full Text] [Related]
18. Nicotinic α4β2 Cholinergic Receptor Influences on Dorsolateral Prefrontal Cortical Neuronal Firing during a Working Memory Task.
Sun Y; Yang Y; Galvin VC; Yang S; Arnsten AF; Wang M
J Neurosci; 2017 May; 37(21):5366-5377. PubMed ID: 28450546
[TBL] [Abstract][Full Text] [Related]
19. alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex.
Livingstone PD; Srinivasan J; Kew JN; Dawson LA; Gotti C; Moretti M; Shoaib M; Wonnacott S
Eur J Neurosci; 2009 Feb; 29(3):539-50. PubMed ID: 19187266
[TBL] [Abstract][Full Text] [Related]
20. A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats.
Koshy Cherian A; Gritton H; Johnson DE; Young D; Kozak R; Sarter M
Neuropharmacology; 2014 Jul; 82():41-8. PubMed ID: 24647121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
